<DOC>
	<DOCNO>NCT00564499</DOCNO>
	<brief_summary>A Scientific Research Program evaluate efficacy SYMBICORT® 320/9μg treatment COPD real life environment General Practitioners</brief_summary>
	<brief_title>SYMBICORT® Treatment COPD</brief_title>
	<detailed_description />
	<mesh_term>Budesonide , Formoterol Fumarate Drug Combination</mesh_term>
	<criteria>patient ( m/f ) COPD ( GOLD stadium III IV ) patient recently quit smoking ( &lt; 3months )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>COPD</keyword>
	<keyword>Symbicort</keyword>
	<keyword>General Practitioners</keyword>
</DOC>